Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation

Folic Acid Supplementation ◽

Host Disease ◽

Acid Supplementation ◽

Graft Versus Host ◽

Hematopoietic Transplantation ◽

Toxicity Risk ◽

Early Toxicity ◽

Infliximab for the Treatment of Severe Steroid Refractory Acute Graft-versus-host Disease in Three Patients after Allogeneic Hematopoietic Transplantation

Leukemia & Lymphoma ◽

10.1080/1042819031000123483 ◽

2003 ◽

Vol 44 (12) ◽

pp. 2095-2097 ◽

Cited By ~ 24

Author(s):

Takahisa Yamane ◽

Ryousuke Yamamura ◽

Yasutaka Aoyama ◽

Hirohisa Nakamae ◽

Taro Hasegawa ◽

...

Keyword(s):

Host Disease ◽

Graft Versus Host ◽

Hematopoietic Transplantation ◽

Allogeneic Hematopoietic Transplantation ◽

Steroid Refractory ◽

Review for "Glucocorticoids delivered by inorganic‐organic hybrid nanoparticles mitigate acute graft‐versus‐host disease and sustain graft‐versus‐leukemia activity"

10.1002/eji.201948464/v2/review1 ◽

2020 ◽

Keyword(s):

Hybrid Nanoparticles ◽

Host Disease ◽

Graft Versus Host ◽

Organic Hybrid ◽

Graft Versus Leukemia ◽

Author response for "Glucocorticoids delivered by inorganic‐organic hybrid nanoparticles mitigate acute graft‐versus‐host disease and sustain graft‐versus‐leukemia activity"

10.1002/eji.201948464/v2/response1 ◽

2020 ◽

Author(s):

Tina K. Kaiser ◽

Hu Li ◽

Laura Roßmann ◽

Sybille D. Reichardt ◽

Hanibal Bohnenberger ◽

...

Keyword(s):

Author Response ◽

Hybrid Nanoparticles ◽

Host Disease ◽

Graft Versus Host ◽

Organic Hybrid ◽

Graft Versus Leukemia ◽

Decision letter for "Glucocorticoids delivered by inorganic‐organic hybrid nanoparticles mitigate acute graft‐versus‐host disease and sustain graft‐versus‐leukemia activity"

10.1002/eji.201948464/v1/decision1 ◽

2020 ◽

Keyword(s):

Hybrid Nanoparticles ◽

Host Disease ◽

Graft Versus Host ◽

Organic Hybrid ◽

Graft Versus Leukemia ◽

EFFECT OF EXTRACORPOREAL PHOTOPHERESIS ON THYMOPOIESIS IN A COHORT OF PAEDIATRIC PATIENTS WITH ACUTE GRAFT-VERSUS-HOST DISEASE

10.26226/morressier.594a7d44d462b8028d89312b ◽

2017 ◽

Author(s):

Flinn Aisling

Keyword(s):

Extracorporeal Photopheresis ◽

Host Disease ◽

Graft Versus Host ◽

Paediatric Patients ◽

Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics

Case Medical Research ◽

10.31525/ct1-nct03862079 ◽

2019 ◽

Author(s):

Keyword(s):

Broad Spectrum ◽

Fecal Transplant ◽

Host Disease ◽

Graft Versus Host ◽

Broad Spectrum Antibiotics ◽

Study of ALPN-101 in Subjects With Steroid-resistant or Steroid-refractory Acute Graft Versus Host Disease

Case Medical Research ◽

10.31525/ct1-nct04227938 ◽

2020 ◽

Author(s):

Keyword(s):

Steroid Resistant ◽

Host Disease ◽

Graft Versus Host ◽

Steroid Refractory ◽

Faculty Opinions recommendation of A biomarker panel for acute graft-versus-host disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1144983.602090 ◽

2009 ◽

Author(s):

Corey Cutler

Keyword(s):

Host Disease ◽

Graft Versus Host ◽

Biomarker Panel ◽

Faculty Opinions recommendation of Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727254630.793528421 ◽

2017 ◽

Author(s):

Nelson Chao

Keyword(s):

Host Disease ◽

Graft Versus Host ◽

Faculty Opinions recommendation of Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8136969.8536079 ◽

2011 ◽

Cited By ~ 1

Author(s):

Jacob Rowe ◽

Tsila Zuckerman

Keyword(s):

Risk Factors ◽

Comparative Analysis ◽

National Institutes Of Health ◽

Host Disease ◽

Graft Versus Host ◽